Myocardial Perfusion Magnetic Resonance Imaging Using Regadenoson
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This is a pilot study to determine whether the drug regadenoson can be used during magnetic
resonance imaging to assess regions of poor blood flow to the heart.
The hypothesis of this study is that a single injection of regadenoson could be used instead
of a standard adenosine infusion to produce coronary vasodilatation and demonstrate
myocardial ischemia during first-pass perfusion cardiac MRI.